bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 11, 2024
Genetic
vascular
disorders
are
prevalent
diseases
that
have
diverse
etiologies
and
few
treatment
options.
Pathogenic
missense
mutations
in
the
alpha
actin
isotype
2
gene
(
Journal of Controlled Release,
Год журнала:
2024,
Номер
375, С. 366 - 388
Опубликована: Сен. 18, 2024
Recent
advancements
in
RNA
therapeutics
highlight
the
critical
need
for
precision
gene
delivery
systems
that
target
specific
organs
and
cells.
Lipid
nanoparticles
(LNPs)
have
emerged
as
key
vectors
delivering
mRNA
siRNA,
offering
protection
against
enzymatic
degradation,
enabling
targeted
cellular
uptake,
facilitating
cargo
release
into
cytosol.
This
review
discusses
development
optimization
of
organ-
cell-specific
LNPs,
focusing
on
their
design,
mechanisms
action,
therapeutic
applications.
We
explore
innovations
such
DNA/RNA
barcoding,
which
facilitates
high-throughput
screening
precise
adjustments
formulations.
address
major
challenges,
including
improving
endosomal
escape,
minimizing
off-target
effects,
enhancing
efficiencies.
Notable
clinical
trials
recent
FDA
approvals
illustrate
practical
applications
future
potential
LNP-based
therapies.
Our
findings
suggest
while
considerable
progress
has
been
made,
continued
research
is
essential
to
resolve
existing
limitations
bridge
gap
between
pre-clinical
evaluation
safety
efficacy
therapeutics.
highlights
dynamic
LNP
research.
It
outlines
a
roadmap
RNA-based
medicine.
Nature Biotechnology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 20, 2025
Abstract
Cell-type-specific
regulatory
elements
such
as
enhancers
can
direct
expression
of
recombinant
adeno-associated
viruses
(AAVs)
to
specific
cell
types,
but
this
approach
is
limited
by
the
relatively
small
packaging
capacity
AAVs.
In
study,
we
used
spatial
genomics
show
that
transcriptional
crosstalk
between
individual
AAV
genomes
provides
a
general
method
for
cell-type-specific
large
cargo
separating
distally
acting
into
second
genome.
We
identified
and
profiled
in
carrying
11
different
active
mouse
brain.
developed
methods
identify
localize
their
concatemeric
forms
cultured
cells
tissue,
demonstrate
here
dependent
upon
concatemer
formation.
Finally,
leveraged
drive
3.2-kb
Cas9
manner
with
systemically
administered
engineered
AAVs,
AAV-delivered,
minimally
invasive,
gene
editing
wild-type
mice
recapitulates
known
disease
phenotypes.
Proceedings of the National Academy of Sciences,
Год журнала:
2024,
Номер
121(11)
Опубликована: Март 4, 2024
Due
to
its
small
size
and
lifelong
optical
transparency,
the
fish
Danionella
cerebrum
is
an
emerging
model
organism
in
biomedical
research.
How
can
this
vertebrate
under
12
mm
length
produce
sounds
over
140
dB?
We
found
that
it
possesses
...Motion
basis
of
nearly
all
animal
behavior.
Evolution
has
led
some
extraordinary
specializations
propulsion
mechanisms
among
invertebrates,
including
mandibles
dracula
ant
claw
pistol
shrimp.
In
contrast,
...
Journal of Controlled Release,
Год журнала:
2024,
Номер
370, С. 239 - 255
Опубликована: Апрель 27, 2024
Double
pH-responsive
xenopeptide
carriers
containing
succinoyl
tetraethylene
pentamine
(Stp)
and
lipo
amino
fatty
acids
(LAFs)
were
evaluated
for
CRISPR/Cas9
based
genome
editing.
Different
carrier
topologies,
variation
of
LAF/Stp
ratios
LAF
types
as
Cas9
mRNA/sgRNA
polyplexes
screened
in
three
different
reporter
cell
lines
using
genomic
targets
(Pcsk9,
eGFP,
mdx
exon
23).
One
U-shaped
bundle
(B2)-shaped
lipo-xenopeptides
exhibiting
remarkable
efficiencies
identified.
Genome
editing
potency
top
observed
at
sub-nanomolar
EC
European Journal of Pharmaceutical Sciences,
Год журнала:
2024,
Номер
205, С. 106983 - 106983
Опубликована: Дек. 7, 2024
Clustered
regularly
interspaced
short
palindromic
repeat
(CRISPR)/CRISPR
associated
(Cas)
protein
has
been
proved
as
a
powerful
tool
for
the
treatment
of
genetic
diseases.
The
Cas9
protein,
when
combined
with
single-guide
RNA
(sgRNA),
forms
Cas9/sgRNA
ribonucleoprotein
(RNP)
capable
targeting
and
editing
genome.
However,
limited
availability
effective
carriers
restricted
broader
application
CRISPR/Cas9
RNP.
In
this
study,
we
evaluated
dual
pH-responsive
amphiphilic
xenopeptides
(XPs)
delivering
These
artificial
lipo-XPs
contain
apolar
cationizable
lipoamino
fatty
acid
(LAF)
polar
oligoaminoethylene
units
such
succinoyl-tetraethylenepentamine
(Stp)
in
various
ratios
U-shaped
topologies.
were
screened
functional
RNP
delivery
four
different
reporter
cell
lines,
including
Duchenne
muscular
dystrophy
(DMD)
exon
skipping
model.
Significantly
enhanced
cellular
uptake
into
HeLa
cells,
endosomal
disruption
gal8-mRuby3
potent
genome
by
several
complexes
was
observed
lines
5
nM
sgRNA
range.
Comparing
mRNA/sgRNA
polyplexes
DMD
model
demonstrated
similar
splice
site
high
two
molecular
modalities.
Based
on
these
studies,
analogues
U1
LAF2-Stp
LAF4-Stp2
structures
deployed,
tuning
amphiphilicity
Stp
group
replacement
six
oligoamino
acids
dmGtp,
chGtp,
dGtp,
Htp,
Stt,
or
GEIPA.
most
(containing
chGtp
GEIPA)
further
gene
efficiency
EC50
values
1
line.
Notably,
LAF2-dGtp
reached
0.51
even
upon
serum
incubation.
Another
carrier
(LAF4-GEIPA2)
complexing
donor
DNA,
facilitated
up
to
43
%
homology-directed
repair
(HDR)
eGFPd2
cells
visualized
switch
from
green
fluorescent
(eGFP)
blue
(BFP).
This
study
presents
system
tunable
RNP/donor
DNA
polyplexes,
offering
an
easily
applicable
strategy
editing.